Clinical Trials Sponsored by Pulmonx International Sàrl

Total 39 results

Pulmonx International Sàrl

Terminated

Long Term Follow up Investigation of Endobronchial Valves in Emphysema (LIVE)

Pulmonary Emphysema

Germany
Pulmonx International Sàrl

Completed

Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study (IMPACT)

COPD Patients With Homogeneous Emphysema | Endoscopic Lung Volume Reduction With Endobronchial Valve

Germany, Austria, Netherlands
Mesoblast International Sàrl

No longer available

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19

United States
Medos International SARL

Recruiting

A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis

Intracranial Atherosclerosis

China
Mesoblast International Sàrl

Available

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
MedSIR
Incyte Biosciences International Sàrl

Active, not recruiting

Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS) (ORPHEUS)

Penile Cancer

Spain, Italy
Mesoblast International Sàrl

Completed

Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy

Recovery Following Partial Medial Meniscectomy

United States
Incyte Biosciences International Sàrl

Completed

A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

Metastatic Cancer | Advanced Malignancies

United States
Incyte Biosciences International Sàrl

Completed

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Advanced Malignancies

United States
Incyte Biosciences International Sàrl

Terminated

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Metastatic Cancer | Advanced Malignancies

United States
Incyte Biosciences International Sàrl

Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Cervical Cancer | Hepatocellular Carcinoma | Esophageal Cancer | Ovarian Cancer | Mesothelioma | Non-small Cell Lung Cancer (NSCLC) | Urothelial Carcinoma | Merkel Cell Carcinoma | Diffuse Large B-cell Lymphoma | Triple-negative Breast Cancer | Renal Cell Carcinoma (RCC) | Small Cell Lung Cancer (SCLC) | Squamous... and other conditions

United States
Incyte Biosciences International Sàrl

Withdrawn

A Study to Evaluate Effectiveness and Safety of Ponatinib in Patients With BCR-ABL Positive ALL in Standard Clinical Practice in Europe - "POSEIDON"

BCR-ABL Positive Acute Lymphoblastic Leukemia

Germany, France, Czechia
Incyte Biosciences International Sàrl

Recruiting

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

United States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
Institut Bergonié
Incyte Biosciences International Sàrl

Recruiting

Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) (TORNADO)

Resectable Sarcoma

France
Incyte Biosciences International Sàrl

Recruiting

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Lymphoma | Acute Myeloid Leukemia | Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Solid Tumors | Chronic Phase Chronic Myeloid Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blast Phase Chronic Myeloid Leukemia

Spain, Italy, France, Germany, United Kingdom, Belgium, Sweden, Denmark, Netherlands
Incyte Biosciences International Sàrl

Withdrawn

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma | Advanced Malignancies | Metastatic Head and Neck Squamous Cell Carcinoma

United States
Incyte Biosciences International Sàrl

Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Metastatic Cancer | Advanced Malignancies

United States, Belgium, Australia, Spain
Incyte Biosciences International Sàrl

Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

Metastatic Cancer | Advanced Malignancies

United States, United Kingdom, Spain, Switzerland
GWT-TUD GmbH
Incyte Biosciences International Sàrl

Terminated

Study in Patients With Chronic Leukemia (PONS)

Leukemia, Myeloid, Chronic-Phase

Germany
Complife Italia Srl
Macrofarm Srl; Icim International Srl

Completed

EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS) (EVAANIS)

Oxidative Stress

Italy
Correvio International Sarl

Completed

Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)

Atrial Fibrillation

Denmark, Spain, Austria, Finland, Germany, Sweden
Ceric Sàrl
European Cardiovascular Research Center; Biosensors International

Not yet recruiting

All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve

Aortic Stenosis, Severe
Mesoblast International Sàrl
National Cancer Institute (NCI)

Withdrawn

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Myelodysplastic Syndromes | Leukemia | Graft Versus Host Disease

United States
Medos International SARL
Johnson & Johnson Medical (Shanghai) Ltd.

Active, not recruiting

Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms (EMPOWER)

Intracranial Aneurysm

China
Helsinki University Central Hospital
Medtronic International Trading Sarl

Recruiting

Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years

Type 1 Diabetes

Finland
Kinderkrankenhaus auf der Bult
Medtronic International Trading Sarl

Completed

"MiniMed 640G System" User Evaluation With the Question of Reducing the Rate of Hypoglycemia

Type 1 Diabetes

Germany
Correvio International Sarl
PrimeVigilance; Universal Medical Group

Completed

Xydalba Utilization Registry in France

Bacterial Infections

France
Institut für Klinische Krebsforschung IKF GmbH...
Incyte Biosciences International Sàrl

Recruiting

Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements

Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Gene Translocation | FGFR2 Gene Rearrangement

Germany
Concordia Dent Srl
ITI International Team for Implantology, Switzerland

Completed

Clinical Study on the Efficiency of Three Different Attachment Systems for Implant-supported Mandibular Overdenture

MANDIBLE | ATROPHYC EDENTULOUS JAW

Romania
Concordia Dent Srl
ITI International Team for Implantology, Switzerland

Completed

Validation and Cross-Cultural Adaptation of the Romanian Version of Oral Health Impact Profile in Edentulous Adults (ROM-OHIP-ED)

Severe Atrophy of the Edentulous Mandible

Romania
Medtronic Cardiac Rhythm and Heart Failure
Medtronic International Trading Sarl

Completed

Durability of Pulmonary Vein Isolation Following Cryoablation for Treatment of Paroxysmal Atrial Fibrillation (SUPIR)

Paroxysmal Atrial Fibrillation

Czechia
Correvio International Sarl
PrimeVigilance; AMS Advanced Medical Services GmbH

Terminated

Xydalba Utilization Registry in Germany

Bacterial Infections

Germany
Liverpool Heart and Chest Hospital NHS Foundation...
Medtronic International Trading Sarl

Completed

Cryoballoon Ablation as First Line Treatment of Atrial Flutter (CRAFT)

Atrial Flutter Typical

United Kingdom, Switzerland
European Association of Urology Research Foundation
Incyte Biosciences International Sàrl; AMS Advanced Medical Services GmbH; High...

Terminated

Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery (PEGASUS)

Urothelial Cancer

Italy
GlaxoSmithKline
Q2 Solutions; York Bioanalytical Solution; BI Medical.Inc; SRL Mediserch.Inc; Parexel...

Completed

A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma

Asthma

Japan
Farmacia La Regina s.r.l.
Federfarma Campania; Federfarma Salerno; HTN - Health Telematic Network srl; BSI... and other collaborators

Completed

New Patient Support Program in Type 2 Diabetes

Diabetes Mellitus, Type 2

Italy
Tangent Data
Stanley Medical Research Institute; MediStat Ltd.; PCI pharma services (formerly... and other collaborators

Unknown

Estradiol as add-on to Antipsychotics (EST-S-02)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders

Moldova, Republic of
Mesoblast International Sàrl
University of Southern California; OrthoIndy; TRIA Orthopaedic Center; Midwest... and other collaborators

Completed

A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy

Recovery Following Partial Medial Meniscectomy

United States
Harokopio University
Monash University; National and Kapodistrian University of Athens; University... and other collaborators

Recruiting

Promote Health With Digital Tools Among Adults With Type 2 Diabetes/Prediabetes and/or Hypertension (DigiCare4You)

Hypertension | PreDiabetes | Type 2 Diabetes

Albania, Bulgaria, Greece, Spain

Clinical Trials Sponsored by Pulmonx International Sàrl

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations